Difficulty: Medium
Average Score: 93%
Practice
What type of testing should be offered to a patient who has had a stillbirth?
Correct answer
C
Rationale
In the context of a patient who has experienced a stillbirth, the most appropriate testing to offer is placental pathology (Option C). Placental pathology examination can provide crucial insights into the cause of the stillbirth, such as identifying abnormalities in the placenta that could have contributed to the tragic event. By analyzing the placenta, healthcare providers can gather valuable information that may help in understanding the underlying reasons for the stillbirth and guide future management or counseling.
Option A, NIPTs (Non-Invasive Prenatal Testing), is not typically indicated in the evaluation of stillbirth. NIPTs are primarily used for prenatal screening in pregnancies that are ongoing to assess the risk of chromosomal abnormalities such as Down syndrome.
Option B, ultrasound, may have been helpful during the pregnancy to monitor fetal development and well-being but is less likely to provide detailed information post-stillbirth compared to placental pathology.
Option D, blood crossmatch, is not directly relevant to investigating the cause of a stillbirth. Blood crossmatching is a test done to determine compatibility between blood donor and recipient before a transfusion, and it does not play a role in evaluating a stillbirth.
Understanding the importance of appropriate testing in different clinical scenarios is essential for healthcare providers, especially in sensitive situations like stillbirth, where thorough investigation is crucial for both emotional closure and future pregnancy planning. Placental pathology stands out in this scenario due to its direct relevance in providing insights into the cause of the adverse outcome.
Option A, NIPTs (Non-Invasive Prenatal Testing), is not typically indicated in the evaluation of stillbirth. NIPTs are primarily used for prenatal screening in pregnancies that are ongoing to assess the risk of chromosomal abnormalities such as Down syndrome.
Option B, ultrasound, may have been helpful during the pregnancy to monitor fetal development and well-being but is less likely to provide detailed information post-stillbirth compared to placental pathology.
Option D, blood crossmatch, is not directly relevant to investigating the cause of a stillbirth. Blood crossmatching is a test done to determine compatibility between blood donor and recipient before a transfusion, and it does not play a role in evaluating a stillbirth.
Understanding the importance of appropriate testing in different clinical scenarios is essential for healthcare providers, especially in sensitive situations like stillbirth, where thorough investigation is crucial for both emotional closure and future pregnancy planning. Placental pathology stands out in this scenario due to its direct relevance in providing insights into the cause of the adverse outcome.